Carregant...
Emerging therapeutic paradigms to target the dysregulated JAK/STAT pathways in hematological malignancies
Over the past decade, there has been increasing biochemical evidence that the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is aberrantly activated in malignant cells from patients with a wide spectrum of cancers of the blood and immune systems. The emerging avai...
Guardat en:
| Publicat a: | Leuk Lymphoma |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4344832/ https://ncbi.nlm.nih.gov/pubmed/24206094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.863307 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|